Multiplexed invivo fluorescence optical imaging of the therapeutic efficacy of photodynamic therapy

Biomaterials

Volumn 34, Issue 38, 2013, Pages 10075-10083

  Haedicke, Katja ^a   Gräfe, Susanna ^b   Lehmann, Frank ^c   Hilger, Ingrid ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Biolitec Research GmbH   (Germany)

^c Dyomics GmbH   (Germany)

Author keywords

Annexin V; Apoptosis; Fluorescence optical imaging; Multiplexed imaging; Tumor vascularization

Indexed keywords

ANNEXINS; COUPLING EFFICIENCY; FLUORESCENCE OPTICAL IMAGING; NEAR-INFRARED DYES; PHOTODYNAMIC THERAPY (PDT); SPECTROSCOPIC PROPERTY; THERAPEUTIC EFFICACY; TUMOR VASCULARIZATION;

ANTIBIOTICS; BINDING ENERGY; CELL DEATH; FLUORESCENCE; MULTIPLEXING; OPTICAL IMAGE STORAGE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

TUMORS;

FOSLIP; LIPOCORTIN 5; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CANCER SIZE; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TONGUE CARCINOMA; TUMOR VASCULARIZATION; ANIMAL; FLUORESCENCE MICROSCOPY; FLUORESCENCE OPTICAL IMAGING; GENETICS; METABOLISM; METHODOLOGY; MULTIPLEXED IMAGING; PHOTOCHEMOTHERAPY; PHYSIOLOGY; TUMOR CELL LINE;

MUS;

ANNEXIN V; APOPTOSIS; FLUORESCENCE OPTICAL IMAGING; MULTIPLEXED IMAGING; TUMOR VASCULARIZATION;

ANIMALS; ANNEXIN A5; APOPTOSIS; CELL LINE, TUMOR; FEMALE; MICE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY;

EID: 84885384689     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.087     Document Type: Article

References (42)

1. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17(5):545-580.
2. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011, 61(4):250-281.
3. Dome B., Hendrix M.J., Paku S., Tovari J., Timar J. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007, 170(1):1-15.
4. Miller J.C., Pien H.H., Sahani D., Sorensen A.G., Thrall J.H. Imaging angiogenesis: applications and potential for drug development. JNatl Cancer Inst 2005, 97(3):172-187.
5. Moor A.C. Signaling pathways in cell death and survival after photodynamic therapy. JPhotochem Photobiol B 2000, 57(1):1-13.
6. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. JImmunol 1992, 148(7):2207-2216.
7. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31(1):1-9.
8. Zhang G., Gurtu V., Kain S.R., Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997, 23(3):525-531.
9. Subbarayan M., Hafeli U.O., Feyes D.K., Unnithan J., Emancipator S.N., Mukhtar H. Asimplified method for preparation of 99mTc-annexin V and its biologic evaluation for invivo imaging of apoptosis after photodynamic therapy. JNucl Med 2003, 44(4):650-656.
10. Vangestel C., Peeters M., Oltenfreiter R., D'Asseler Y., Staelens S., Van Steenkiste M., et al. Invitro and invivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Nucl Med Biol 2010, 37(8):965-975.
11. Cauchon N., Langlois R., Rousseau J.A., Tessier G., Cadorette J., Lecomte R., et al. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging 2007, 34(2):247-258.
12. Ntziachristos V., Schellenberger E.A., Ripoll J., Yessayan D., Graves E., Bogdanov A., et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004, 101(33):12294-12299.
13. Petrovsky A., Schellenberger E., Josephson L., Weissleder R., Bogdanov A. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 2003, 63(8):1936-1942.
14. Lederle W., Arns S., Rix A., Gremse F., Doleschel D., Schmaljohann J., et al. Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects. EJNMMI Res 2011, 1(1):26.
15. Lassalle H.P., Wagner M., Bezdetnaya L., Guillemin F., Schneckenburger H. Fluorescence imaging of Foscan and Foslip in the plasma membrane and in whole cells. JPhotochem Photobiol B 2008, 92(1):47-53.
16. Kiesslich T., Berlanda J., Plaetzer K., Krammer B., Berr F. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Photochem Photobiol Sci 2007, 6(6):619-627.
17. Teiten M.H., Bezdetnaya L., Morliere P., Santus R., Guillemin F. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br J Cancer 2003, 88(1):146-152.
18. Teiten M.H., Marchal S., D'Hallewin M.A., Guillemin F., Bezdetnaya L. Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells. Photochem Photobiol 2003, 78(1):9-14.
19. Svensson J., Johansson A., Grafe S., Gitter B., Trebst T., Bendsoe N., et al. Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model. Photochem Photobiol 2007, 83(5):1211-1219.
20. Mentinova M., McLuckey S.A. Covalent modification of gaseous peptide ions with N-hydroxysuccinimide ester reagent ions. JAm Chem Soc 2010, 132(51):18248-18257.
21. Schonn I., Hennesen J., Dartsch D.C. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 2010, 15(2):162-172.
22. Yang T.J., Haimovitz-Friedman A., Verheij M. Anticancer therapy and apoptosis imaging. Exp Oncol 2012, 34(3):269-276.
23. Blankenberg F.G., Tait J., Ohtsuki K., Strauss H.W. Apoptosis: the importance of nuclear medicine. Nucl Med Commun 2000, 21(3):241-250.
24. Yen T.C., Wey S.P., Liao C.H., Yeh C.H., Shen D.W., Achilefu S., et al. Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions. Anal Biochem 2010, 406(1):70-79.
25. Andree H.A., Reutelingsperger C.P., Hauptmann R., Hemker H.C., Hermens W.T., Willems G.M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. JBiol Chem 1990, 265(9):4923-4928.
26. Reutelingsperger C.P., van Heerde W.L. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997, 53(6):527-532.
27. van Heerde W.L., Poort S., van't Veer C., Reutelingsperger C.P., de Groot P.G. Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation. Biochem J 1994, 302(Pt 1):305-312.
28. Pauli J., Brehm R., Spieles M., Kaiser W.A., Hilger I., Resch-Genger U. Novel fluorophores as building blocks for optical probes for invivo near infrared fluorescence (NIRF) imaging. JFluoresc 2010, 20(3):681-693.
29. Pauli J., Vag T., Haag R., Spieles M., Wenzel M., Kaiser W.A., et al. An invitro characterization study of new near infrared dyes for molecular imaging. Eur J Med Chem 2009, 44(9):3496-3503.
30. Agarwal M.L., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 1991, 51(21):5993-5996.
31. Zaidi S.I., Oleinick N.L., Zaim M.T., Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol 1993, 58(6):771-776.
32. Dolmans D.E., Kadambi A., Hill J.S., Flores K.R., Gerber J.N., Walker J.P., et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002, 62(15):4289-4294.
33. Fingar V.H., Wieman T.J., Wiehle S.A., Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 1992, 52(18):4914-4921.
34. Gaertner F.C., Kessler H., Wester H.J., Schwaiger M., Beer A.J. Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging 2012, 39(Suppl.1):S126-S138.
35. Marshall M.V., Draney D., Sevick-Muraca E.M., Olive D.M. Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 2010, 12(6):583-594.
36. Gillies R.J., Schornack P.A., Secomb T.W., Raghunand N. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1999, 1(3):197-207.
37. Maeda H., Nakamura H., Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging invivo. Adv Drug Deliv Rev 2013, 65(1):71-79.
38. Blankenberg F.G., Katsikis P.D., Tait J.F., Davis R.E., Naumovski L., Ohtsuki K., et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. JNucl Med 1999, 40(1):184-191.
39. Tait J.F., Cerqueira M.D., Dewhurst T.A., Fujikawa K., Ritchie J.L., Stratton J.R. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res 1994, 75(5):491-501.
40. Wen X., Wu Q.P., Ke S., Wallace S., Charnsangavej C., Huang P., et al. Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis. Cancer Biother Radiopharm 2003, 18(5):819-827.
41. Hamann F.M., Brehm R., Pauli J., Grabolle M., Frank W., Kaiser W.A., et al. Controlled modulation of serum protein binding and biodistribution of asymmetric cyanine dyes by variation of the number of sulfonate groups. Mol Imaging 2011, 10(4):258-269.
42. Busch C., Passon M., Wenzel M., Socher I., Kaiser W.A., Hilger I. Detection of leukotriene receptor CysLT1R in inflammatory diseases by molecular imaging with near-infrared fluorescence-based contrast agents. Mol Imaging 2011, 10(2):81-90.